Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to sign a written consent form agreeing to take part
- People who are 18 years of age or older
- People who have been diagnosed with prostate cancer (specifically a type called adenocarcinoma), confirmed by a tissue or cell sample test
- People who have been confirmed to have prostate cancer that has spread to other parts of the body and is no longer responding to hormone therapy (known as metastatic castration-resistant prostate cancer)
- People who have started treatment with olaparib plus abiraterone after the trial site began accepting participants
Who may not be able to join:
- People who took part in another clinical trial testing an investigational prostate cancer treatment within 30 days before starting olaparib
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-877-240-9479
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time to treatment discontinuation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.